Companies also went shopping on the Presidents Day holiday weekend as Actavis bought Forest Laboratories for $25 billion and Ashland sold its water treatment unit for $1.8 billion. Carl Icahn must be especially happy with the Forest Labs sale as he tried not, once, but twice to get the company to sell itself and still owns a stake in the biotech. It also augurs well for Wall Street advisers who have been waiting for a recovering economy to support an uptick in mergers and acquisitions.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.